Skip to main content
FDA Shortage Check

Is Vyvanse (Lisdexamfetamine Dimesylate Capsule) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Vyvanse: in shortage (FDA, Oct 24)

Capsules
A generic capsule, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Shortage of an active ingredient”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: TBD”. Manufacturer’s estimate, Elite Laboratories, Inc., Oct 15, 2026
DRUG
Vyvanse
FDA LISTING
FORM
capsules
STATUS
Currently in Shortage
FIRST POSTED
Jul 14, 2023
LAST FDA UPDATE
Oct 19, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 90 presentations: 0 unavailable · 36 limited · 54 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Lisdexamfetamine Dimesylate Capsule. 90 presentations from 13 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Elite Laboratories, Inc.7 presentations · 7 limited

Contact (FDA's listing): 888-852-6657

  • 10 mg

    Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01)

    Estimated recovery: TBD

    NDC 64850-550-01Reverified

    Limited Availability

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01)

    Estimated recovery: TBD

    NDC 64850-551-01Reverified

    Limited Availability

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01)

    Estimated recovery: TBD

    NDC 64850-552-01Reverified

    Limited Availability

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01)

    Estimated recovery: TBD

    NDC 64850-553-01Reverified

    Limited Availability

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01)

    Estimated recovery: TBD

    NDC 64850-554-01Reverified

    Limited Availability

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01)

    Estimated recovery: TBD

    NDC 64850-555-01Reverified

    Limited Availability

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01)

    Estimated recovery: TBD

    NDC 64850-556-01Reverified

    Limited Availability

Hikma Pharmaceuticals USA, Inc.7 presentations · 7 limited

Contact (FDA's listing): 800-631-2174

  • 10 mg

    Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25)

    Available on allocation

    NDC 0054-0660-25Revised

    Limited Availability

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25)

    Available on allocation

    NDC 0054-0370-25Reverified

    Limited Availability

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25)

    Available on allocation

    NDC 0054-0371-25Reverified

    Limited Availability

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25)

    Available on allocation

    NDC 0054-0372-25Reverified

    Limited Availability

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25)

    Available on allocation

    NDC 0054-0373-25Reverified

    Limited Availability

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25)

    Available on allocation

    NDC 0054-0374-25Reverified

    Limited Availability

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25)

    Available on allocation

    NDC 0054-0375-25Reverified

    Limited Availability

Lannett Company, Inc.7 presentations · 3 limited · 4 available or not stated

Contact (FDA's listing): 844-834-0530

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37)

    Estimated recovery: October 2026

    NDC 0527-4662-37Revised

    Limited Availability

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37)

    Estimated recovery: October 2026

    NDC 0527-4663-37Revised

    Limited Availability

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37)

    Estimated recovery: October 2026

    NDC 0527-4664-37Revised

    Limited Availability

  • 10 mg

    Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37)

    NDC 0527-4661-37Reverified

    Available

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37)

    NDC 0527-4665-37Reverified

    Available

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37)

    NDC 0527-4666-37Reverified

    Available

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37)

    NDC 0527-4667-37Reverified

    Available

Rhodes Pharmaceuticals L.P.7 presentations · 5 limited · 2 available or not stated

Contact (FDA's listing): 888-827-0616

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01)

    Estimated recovery: TBD

    NDC 42858-162-01Revised

    Limited Availability

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01)

    Estimated recovery: TBD

    NDC 42858-163-01Revised

    Limited Availability

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01)

    Estimated recovery: TBD

    NDC 42858-164-01Revised

    Limited Availability

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01)

    Estimated recovery: TBD

    NDC 42858-165-01Revised

    Limited Availability

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01)

    Estimated recovery: TBD

    NDC 42858-167-01Revised

    Limited Availability

  • 10 mg

    Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01)

    NDC 42858-161-01Revised

    Available

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01)

    NDC 42858-166-01Revised

    Available

Solco Healthcare US, LLC7 presentations · 7 limited

Contact (FDA's listing): 866-931-9829

  • 10 mg

    Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10)

    On allocation

    NDC 43547-602-10Reverified

    Limited Availability

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10)

    On allocation

    NDC 43547-603-10Reverified

    Limited Availability

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10)

    On allocation

    NDC 43547-604-10Reverified

    Limited Availability

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10)

    On allocation

    NDC 43547-605-10Reverified

    Limited Availability

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10)

    On allocation

    NDC 43547-606-10Reverified

    Limited Availability

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10)

    On allocation

    NDC 43547-607-10Reverified

    Limited Availability

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10)

    On allocation

    NDC 43547-608-10Reverified

    Limited Availability

Sun Pharmaceutical Industries, Inc.7 presentations · 7 limited

Contact (FDA's listing): 800-818-4555

  • 10 mg

    Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88)

    Estimated Recovery: TBD

    NDC 57664-046-88Reverified

    Limited Availability

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88)

    Estimated Recovery: TBD

    NDC 57664-047-88Reverified

    Limited Availability

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-048-88)

    Estimated Recovery: TBD

    NDC 57664-048-88Reverified

    Limited Availability

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88)

    Estimated Recovery: TBD

    NDC 57664-049-88Reverified

    Limited Availability

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88)

    Estimated Recovery: TBD

    NDC 57664-050-88Reverified

    Limited Availability

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88)

    Estimated Recovery: TBD

    NDC 57664-051-88Reverified

    Limited Availability

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88)

    Estimated Recovery: TBD

    NDC 57664-052-88Reverified

    Limited Availability

Alvogen7 presentations · 7 available or not stated

Contact (FDA's listing): 844-842-8672 and email: CustomerService-US@alvogen.com

  • 10 mg

    Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01)

    NDC 47781-562-01Reverified

    Available

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01)

    NDC 47781-563-01Reverified

    Available

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01)

    NDC 47781-564-01Reverified

    Available

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01)

    NDC 47781-565-01Reverified

    Available

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01)

    NDC 47781-566-01Reverified

    Available

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01)

    NDC 47781-567-01Reverified

    Available

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01)

    NDC 47781-568-01Reverified

    Available

Amneal Pharmaceuticals6 presentations · 6 available or not stated

Contact (FDA's listing): 866-525-7270

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09)

    NDC 65162-023-09Reverified

    Available

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)

    NDC 65162-024-09Reverified

    Available

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09)

    NDC 65162-025-09Reverified

    Available

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09)

    NDC 65162-026-09Reverified

    Available

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09)

    NDC 65162-027-09Reverified

    Available

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09)

    NDC 65162-028-09Reverified

    Available

Apotex Corp.7 presentations · 7 available or not stated

Contact (FDA's listing): 800-706-5575

  • 10 mg

    Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1)

    NDC 60505-4739-1Reverified

    Available

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1)

    NDC 60505-4740-1Revised

    Available

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1)

    NDC 60505-4741-1Reverified

    Available

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1)

    NDC 60505-4742-1Reverified

    Available

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)

    NDC 60505-4743-1Reverified

    Available

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1)

    NDC 60505-4744-1Reverified

    Available

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1)

    NDC 60505-4745-1Reverified

    Available

Mylan Pharmaceuticals Inc., a Viatris Company7 presentations · 7 available or not stated

Contact (FDA's listing): 800-796-9526

  • 10 mg

    Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77)

    NDC 0378-6854-77Reverified

    Available

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77)

    NDC 0378-6855-77Reverified

    Available

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77)

    NDC 0378-6856-77Reverified

    Available

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77)

    NDC 0378-6857-77Reverified

    Available

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77)

    NDC 0378-6858-77Reverified

    Available

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)

    NDC 0378-6859-77Reverified

    Available

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77)

    NDC 0378-6860-77Reverified

    Available

SpecGx LLC7 presentations · 7 available or not stated

Contact (FDA's listing): 800-325-8888

  • 10 mg

    Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01)

    NDC 0406-5111-01Reverified

    Available

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01)

    NDC 0406-5112-01Reverified

    Available

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01)

    NDC 0406-5113-01Reverified

    Available

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01)

    NDC 0406-5114-01Reverified

    Available

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01)

    NDC 0406-5115-01Reverified

    Available

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01)

    NDC 0406-5116-01Reverified

    Available

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01)

    NDC 0406-5117-01Reverified

    Available

Takeda Pharmaceuticals USA Inc.7 presentations · 7 available or not stated

Contact (FDA's listing): 877-TAKEDA-7 (1-877-825-3327)

  • 10 mg

    Vyvanse, Capsule, 10 mg (NDC 59417-101-10)

    NDC 59417-101-10Reverified

    Available

  • 20 mg

    Vyvanse, Capsule, 20 mg (NDC 59417-102-10)

    NDC 59417-102-10Reverified

    Available

  • 30 mg

    Vyvanse, Capsule, 30 mg (NDC 59417-103-10)

    NDC 59417-103-10Reverified

    Available

  • 40 mg

    Vyvanse, Capsule, 40 mg (NDC 59417-104-10)

    NDC 59417-104-10Reverified

    Available

  • 50 mg

    Vyvanse, Capsule, 50 mg (NDC 59417-105-10)

    NDC 59417-105-10Reverified

    Available

  • 60 mg

    Vyvanse, Capsule, 60 mg (NDC 59417-106-10)

    NDC 59417-106-10Reverified

    Available

  • 70 mg

    Vyvanse, Capsule, 70 mg (NDC 59417-107-10)

    NDC 59417-107-10Reverified

    Available

Teva Pharmaceuticals USA, Inc.7 presentations · 7 available or not stated

Contact (FDA's listing): 800-545-8800

  • 10 mg

    Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01)

    NDC 0480-3565-01Reverified

    Available

  • 20 mg

    Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01)

    NDC 0480-3566-01Reverified

    Available

  • 30 mg

    Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01)

    NDC 0480-3567-01Reverified

    Available

  • 40 mg

    Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01)

    NDC 0480-3568-01Reverified

    Available

  • 50 mg

    Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01)

    NDC 0480-3569-01Reverified

    Available

  • 60 mg

    Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01)

    NDC 0480-3570-01Reverified

    Available

  • 70 mg

    Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01)

    NDC 0480-3564-01Reverified

    Available

What the manufacturers told FDA

  • Elite Laboratories, Inc. · ‘Estimated recovery: TBD’ · updated Oct 2026
  • Lannett Company, Inc. · ‘Estimated recovery: October 2026’ · updated Oct 2026
  • Rhodes Pharmaceuticals L.P. · ‘Estimated recovery: TBD’ · updated Jun 2026
  • Sun Pharmaceutical Industries, Inc. · ‘Estimated Recovery: TBD’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Other
  • Shortage of an active ingredient

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Shown as FDA status, not as suggestions.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Vyvanse in shortage?
Yes. As of Oct 24, 2026, FDA lists Lisdexamfetamine Dimesylate Capsule as currently in shortage: 90 presentations, 0 unavailable and 36 limited.
When will the Vyvanse shortage end?
FDA gives no end date. 22 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Vyvanse?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.